Munshi, Nikhil C.

Deep response in multiple myeloma: a critical review.

Fulciniti, M., Munshi, N. C., & Martinez-Lopez, J. (2015) · BioMed Research International

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 40

Immuno-PRISM: A Randomized Phase II Platform Study of Bispecific Antibodies in High-Risk Smoldering Myeloma

Nadeem, O., Magidson, S., Midha, S., O'Donnell, E. K., Hartley-Brown, M. A., Sperling, A. S., Redd, R. A., Marto, M., Davie, C., Ricciardi, C., et al. (2023) · Blood

Multiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research

Cited by 37

Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status

Cea, M., Cagnetta, A., Acharya, C., Acharya, P., Tai, Y.-T., Yang, C., Lovera, D., Soncini, D., Miglino, M., Fraternali-Orcioni, G., et al. (2016) · Clinical Cancer Research

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 28

Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma

Nardone, C., Gao, J., Seo, H.-S., Mintseris, J., Ort, L., Yip, M. C. J., Negasi, M., Besschetnova, A. K., Kamitaki, N., Gygi, S. P., et al. (2025) · Molecular Cell

Ubiquitin and proteasome pathwaysProtein Degradation and Inhibitors

Cited by 22

Structural basis for the midnolin-proteasome pathway and its role in suppressing myeloma

Nardone, C., Gao, J., Seo, H.-S., Mintseris, J., Ort, L., Yip, M. C. J., Negasi, M., Besschetnova, A. K., Kamitaki, N., Gygi, S. P., et al. (2025) · Molecular Cell

Ubiquitin and proteasome pathwaysProtein Degradation and Inhibitors

Cited by 22

IgM-MM is predominantly a pre–germinal center disorder and has a distinct genomic and transcriptomic signature from WM

Bazarbachi, A. H., Avet-Loiseau, H., Szalat, R., Samur, A. A., Hunter, Z., Shammas, M., Corre, J., Fulciniti, M., Anderson, K. C., Parmigiani, G., et al. (2021) · Blood

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 21

Next‐generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles

Bolli, N., Barcella, M., Salvi, E., D'Avila, F., Vendramin, A., De Philippis, C., Munshi, N. C., Avet‐Loiseau, H., Campbell, P. J., Mussetti, A., et al. (2017) · Cancer

Multiple Myeloma Research and TreatmentsGenomics and Rare Diseases

Cited by 17

Development of hyperdiploidy starts at an early age and takes a decade to complete

Samur, M. K., Aktas Samur, A., Shah, P., Park, J. S., Fulciniti, M., Shammas, M., Corre, J., Anderson, K. C., Parmigiani, G., Avet-Loiseau, H., et al. (2025) · Blood

Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics

Cited by 13

Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma

Richardson, P. G., Durie, B. G., Rosiñol, L., Mateos, M.-V., Dispenzieri, A., Moreau, P., Kumar, S., Raje, N., Munshi, N., Laubach, J. P., et al. (2023) · Haematologica

Multiple Myeloma Research and TreatmentsBone health and treatments

Cited by 9

Evolution of Multiple Myeloma from a Genomic Perspective

Maura, F., Samur, M., & Munshi, N. (2026) · Blood

Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research

Cited by 8

Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy

Magrangeas, F., Cherkaoui, M., Bessonneau-Gaborit, V., Derrien, J., Chevalier, C., Guérin-Charbonnel, C., Diamond, B., Samur, M. K., (IFM), I. F. D. M., Hulin, C., et al. (2026) · Nature Medicine

Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research

Cited by 0